Noteworthy among the new findings is that BC increased the risk of developing ER+ (sES, 1.037; 95% CI, 1.008 to 1.067) or ER+/PR+ breast cancer (sES, 1.034; 95% CI, 1.005 to 1.065). Here, ESR1 is linked to breast cancer.